Because it competes at the nicotinamide substrate site rather than the SAM cofactor site, it is also used as the substrate-competitive reference compound against which bisubstrate and covalent NNMT inhibitors are benchmarked
How to use AOD 9604 AOD 9604 is typically administered via subcutaneous injection, though nasal spray formulations are becoming increasingly available
Products referenced are intended for laboratory research use only and are not for human consumption
The proper dose of B12 to stay healthy Those who are likely to need B12 shots include people with the aforementioned symptoms as well as those with illnesses like pernicious anemia, atrophic gastritis, infertility, heart palpitations, celiac disease, Crohns disease, pancreatic insufficiency, or AIDS
Danelli P, Bartolucci C, et al